 
                        | Product NDC: | 0409-2028 | 
| Proprietary Name: | Morphine Sulfate | 
| Non Proprietary Name: | MORPHINE SULFATE | 
| Active Ingredient(s): | .5 mg/mL & nbsp; MORPHINE SULFATE | 
| Administration Route(s): | INTRAVENOUS | 
| Dosage Form(s): | INJECTION, SOLUTION | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 0409-2028 | 
| Labeler Name: | Hospira, Inc. | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | NDA019917 | 
| Marketing Category: | NDA | 
| Start Marketing Date: | 19921030 | 
| Package NDC: | 0409-2028-02 | 
| Package Description: | 10 CARTON in 1 CONTAINER (0409-2028-02) > 1 VIAL, SINGLE-DOSE in 1 CARTON > 30 mL in 1 VIAL, SINGLE-DOSE | 
| NDC Code | 0409-2028-02 | 
| Proprietary Name | Morphine Sulfate | 
| Package Description | 10 CARTON in 1 CONTAINER (0409-2028-02) > 1 VIAL, SINGLE-DOSE in 1 CARTON > 30 mL in 1 VIAL, SINGLE-DOSE | 
| Product NDC | 0409-2028 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | MORPHINE SULFATE | 
| Dosage Form Name | INJECTION, SOLUTION | 
| Route Name | INTRAVENOUS | 
| Start Marketing Date | 19921030 | 
| Marketing Category Name | NDA | 
| Labeler Name | Hospira, Inc. | 
| Substance Name | MORPHINE SULFATE | 
| Strength Number | .5 | 
| Strength Unit | mg/mL | 
| Pharmaceutical Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC] |